< 1 minute read
Sep. 18, 2021

BAY 1214784 Completes Ph. I for Uterine Fibroids With Good Tolerability

BAY 1214784

oral hGnRH-R hormone receptor antagonist to treat of uterine fibroids, Ph. I completed from cell-based 2.5M cmpd HTS + opt. J. Med. Chem., Oct. 22, 2020 issue Bayer AG, Berlin, DE

Drug Hunter Team

October’s molecule, the Bayer hGnRH-R antagonist BAY 1214784 , is intended as an oral, once-daily treatment for uterine fibroids, a highly common problem in adult women that can lead to infertility. Existing treatments include hGnRH-R blockers which have undesirable side effects such as induction of menopausal symptoms due to their influence [...]



Other molecules you may be interested in